Drug of Abuse Testing Market Introduction
The drugs include cocaine, opiates, marijuana, methamphetamine, benzodiazepine, methadone, ecstasy, amphetamine, barbiturates, PCP and others. Drug of abuse testing is a qualitative process and mostly performed in clinical settings. In drug of abuse testing, sample collection is a critical process and requires high integrity. Urine is the most preferable sample for the drug of abuse testing due to the high window of detection and 75% of the clinical settings use urine for testing. Saliva is the second preferable sample for the drug of abuse testing due to a simpler process, but it has a narrow window of detection.

Drug of Abuse Testing Market Overview
Increasing illegal use of drugs for recreational purposes has fuelled the growth of drug of abuse testing market. Further, increasing government pressure to control the illicit drug usage among the adult population has led to the potential growth of the drug of abuse testing market. Government agencies along with public organizations are taking a direct part in controlling drug of abuse and launched many programs in both the public & private sectors. Changing regulatory scenarios has created significant opportunities for a drug of abuse testing manufacturers. Along with these, technology has integrated the existing manual operations and boosted the penetration. Technology has led to the development of a fully automated process with a wide range of drug detection. Others factors like increasing awareness boosted the robust growth of drug of abuse testing market.
North America Drug of Abuse Testing market witnessed significant share due to stringent federal policies. It was followed by the European drug of abuse testing market with stable market growth over the forecast period. Asia Pacific and Latin America Drug of Abuse Testing market has witnessed fastest CAGR due to increasing awareness.
Drug of Abuse Testing market manufacturers include Thermo Fisher Scientific, SYNLAB, Siemens Healthcare Private Limited, Roche Diagnostics, Drägerwerk AG & Co. KGaA, Beckman Coulter, Inc., Abbott Laboratories and others.
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=12&page=requestsample
Report Structure:
Global Drug of Abuse Testing, by Test Type:
• Immunoassay Test
• Point-of-Care Tests
• Chromatography Tests

Global Drug of Abuse Testing, by Sample Type:
• Urine
• Blood
• Saliva

Global Drug of Abuse Testing, by End User:
• Pathology Laboratories
• Hospitals
• Rehabilitation Centers
• Federal Agencies
• Forensic Laboratories
• Clinics
• Others

Global Drug of Abuse Testing, by Region:
• Europe
• North America
• APAC
• Latin America
• Rest of World
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=12&page=askfordiscount

Competitive Landscape:
• Tier 1 players- established companies in the market with major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points

Objectives of the Study:
• To provide with an exhaustive analysis on the global drug of abuse testing market on the basis of test type, sample type, end-user and region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and overall market
• To predict market size, in five key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Table of Contents
1. Introduction
1.1. Scope and Objective
1.2. Assumptions and Acronyms
1.3. Forecast Factors
1.4. Research Methodology
2. Executive Summary
2.1. Industry Cluster Analysis
2.2. Competition Matrix
2.3. Strategies Recommendations
3. Market Definition
3.1. Report Scope (Inclusions & Exclusions)
3.2. Market Segmentation
4. Global Drug of Abuse Testing Market Overview
4.1. Global Drug of Abuse Testing Market Revenue (USD Mn)
5. Key Inclusions
5.1. Porter’s Five Force analysis
5.2. Market Dynamics
5.3. Industry Trends
5.4. Regulatory Guidelines
5.5. Opportunities in Drug of Abuse Testing
6. Competition Dynamics
6.1. Company Share Analysis (2019)
6.2. Top 10 Product Pricing by Region
7. Global Drug of Abuse Testing Market Revenue (USD Mn), 2019-2026 by Test Type
7.1. Key Market Findings
7.2. Long Term ROI Segments
7.3. Revenue Opportunity Influencing Factors
7.4. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2019-2026
7.4.1 Immunoassay Test
7.4.2 POCT Tests
7.4.3 Chromatography Tests
7.4.4 Academic Institutes
8. Global Drug of Abuse Testing Market Revenue (USD Mn), 2019-2026 by Sample Type
8.1. Key Market Findings
8.2. Long Term ROI Segments
8.3. Revenue Opportunity Influencing Factors
8.4. Market Revenue (USD Mn) Assessment and Forecast by Sample Type, 2019-2026
8.4.1 Urine
8.4.2 Saliva
8.4.3 Blood
8.4.4 Others
9. Global Drug of Abuse Testing Market Revenue (USD Mn), 2019-2026 by End User
9.1. Key Market Findings
9.2. Long Term ROI Segments
9.3. Revenue Opportunity Influencing Factors
9.4. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-2026
9.4.1 Pathology Laboratories
9.4.2 Hospitals
9.4.3 Rehabilitation Centres
9.4.4 Federal Agencies
9.4.5 Forensic Laboratories
9.4.6 Clinics
9.4.7 Others
10. Global Drug of Abuse Testing Market Revenue (USD Mn), 2019-2026 by Region
10.1.Key Market Findings
10.2.Long Term ROI Segments
10.3.Revenue Opportunity Influencing Factors
10.4.Market Revenue (USD Mn) Assessment and Forecast by Region,2026
10.4.1 North America
10.4.2 Latin America
10.4.3 Europe
10.4.4 Asia Pacific
10.4.5 Rest of world
11. North America Drug of Abuse Testing Market Revenue (US$ Mn), 2019-2026
11.1. Key Market Findings
11.2. Long Term ROI Segments
11.3. Revenue Opportunity Influencing Factors
11.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026
11.4.1 US
11.4.2 Canada
11.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2019-2026
11.5.3 Immunoassay Test
11.5.4 POCT Tests
11.5.5 Chromatography Tests
11.5.6 Academic Institutes
11.6. Market Revenue (USD Mn) Assessment and Forecast by Sample Type, 2019-2026
11.6.7 Urine
11.6.8 Saliva
11.6.9 Blood
11.6.10 Others
11.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-2026
11.7.11 Pathology Laboratories
11.7.12 Hospitals
11.7.13 Rehabilitation Centres
11.7.14 Federal Agencies
11.7.15 Forensic Laboratories
11.7.16 Clinics
11.7.17 Others
12. Latin America Drug of Abuse Testing Market Revenue (US$ Mn), 2019-2026
12.1. Key Market Findings
12.2. Long Term ROI Segments
12.3. Revenue Opportunity Influencing Factors
12.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026
12.4.1 Brazil
12.4.2 Mexico
12.4.3 Argentina
12.4.4 Rest of Latin America
12.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2019-2026
12.5.5 Immunoassay Test
12.5.6 POCT Tests
12.5.7 Chromatography Tests
12.5.8 Academic Institutes
12.6. Market Revenue (USD Mn) Assessment and Forecast by Sample Type, 2019-2026
12.6.9 Urine
12.6.10 Saliva
12.6.11Blood
12.6.12 Others
12.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-2026
12.7.13 Pathology Laboratories
12.7.14 Hospitals
12.7.15 Rehabilitation Centres
12.7.16 Federal Agencies
12.7.17 Forensic Laboratories
12.7.18 Clinics
12.7.19 Others
13. Europe America Drug of Abuse Testing Market Revenue (US$ Mn), 2019-2026
13.1. Key Market Findings
13.2. Long Term ROI Segments
13.3. Revenue Opportunity Influencing Factors
13.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026
13.4.1 Germany
13.4.2 France
13.4.3 Spain
13.4.4 UK
13.4.5 Russia
13.4.6 Poland
13.4.7 Rest of Europe
13.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2019-2026
13.5.8 Immunoassay Test
13.5.9 POCT Tests
13.5.10Chromatography Tests
13.5.11Academic Institutes
13.6. Market Revenue (USD Mn) Assessment and Forecast by Sample Type, 2019-2026
13.6.12Urine
13.6.13Saliva
13.6.14Blood
13.6.15 Others
13.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-2026
13.7.16 Pathology Laboratories
13.7.17 Hospitals
13.7.18 Rehabilitation Centres
13.7.19 Federal Agencies
13.7.20 Forensic Laboratories
13.7.21 Clinics
13.7.22 Others
14. Asia Pacific America Drug of Abuse Testing Market Revenue (US$ Mn), 2019-2026
14.1. Key Market Findings
14.2. Long Term ROI Segments
14.3. Revenue Opportunity Influencing Factors
14.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026
14.4.1 Emerging Asia
14.4.1.1 China
14.4.1.2 India
14.4.1.3 ASEAN-5
14.4.1.4 Rest of Emerging Asia
14.4.2 Japan
14.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2019-2026
14.5.3 Immunoassay Test
14.5.4 POCT Tests
14.5.5 Chromatography Tests
14.5.6 Academic Institutes
14.6. Market Revenue (USD Mn) Assessment and Forecast by Sample Type, 2019-2026
14.6.7 Urine
14.6.8 Saliva
14.6.9 Blood
14.6.10 Others
14.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-2026
14.7.11 Pathology Laboratories
14.7.12 Hospitals
14.7.13 Rehabilitation Centres
14.7.14 Federal Agencies
14.7.15 Forensic Laboratories
14.7.16 Clinics
14.7.17 Others
15. Rest of World America Drug of Abuse Testing Market Revenue (US$ Mn), 2019-2026
15.1. Key Market Findings
15.2. Long Term ROI Segments
15.3. Revenue Opportunity Influencing Factors
15.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2019-2026
15.4.1 Middle East
15.4.2 South Africa
15.4.3 North Africa
15.4.4 Rest of World
15.5. Market Revenue (USD Mn) Assessment and Forecast by Test Type, 2019-2026
15.5.5 Immunoassay Test
15.5.6 POCT Tests
15.5.7 Chromatography Tests
15.5.8 Academic Institutes
15.6. Market Revenue (USD Mn) Assessment and Forecast by Sample Type, 2019-2026
15.6.9 Urine
15.6.10Saliva
15.6.11Blood
15.6.12 Others
15.7. Market Revenue (USD Mn) Assessment and Forecast by End User, 2019-2026
15.7.13 Pathology Laboratories
15.7.14 Hospitals
15.7.15 Rehabilitation Centres
15.7.16 Federal Agencies
15.7.17 Forensic Laboratories
15.7.18 Clinics
15.7.19 Others
16. Company Profiles
16.1. Competition Landscape
16.2. Global Company Share (USD Mn) Overview, 2019
16.3. Company Profiles
16.3.1 Thermo Fisher Scientific
16.3.1.1 Corporate Overview
16.3.1.2 Financial Performance
16.3.1.3 Peer Comparison & 3C marketing equation
16.3.1.4 Company Strategy & Channel Management
16.3.2 SYNLAB
16.3.2.1 Corporate Overview
16.3.2.2 Financial Performance
16.3.2.3 Peer Comparison & 3C marketing equation
16.3.2.4 Company Strategy & Channel Management
16.3.3 Siemens Healthcare Private Limited
16.3.3.1 Corporate Overview
16.3.3.2 Financial Performance
16.3.3.3 Peer Comparison & 3C marketing equation
16.3.3.4 Company Strategy & Channel Management
16.3.4 Roche Diagnostics
16.3.4.1 Corporate Overview
16.3.4.2 Financial Performance
16.3.4.3 Peer Comparison & 3C marketing equation
16.3.4.4 Company Strategy & Channel Management
16.3.5 Drägerwerk AG & Co. KGaA
16.3.5.1 Corporate Overview
16.3.5.2 Financial Performance
16.3.5.3 Peer Comparison & 3C marketing equation
16.3.5.4 Company Strategy & Channel Management
16.3.6 Beckman Coulter, Inc.
16.3.6.1 Corporate Overview
16.3.6.2 Financial Performance
16.3.6.3 Peer Comparison & 3C marketing equation
16.3.6.4 Company Strategy & Channel Management
16.3.7 Abbott Laboratories
16.3.7.1 Corporate Overview
16.3.7.2 Financial Performance
16.3.7.3 Peer Comparison & 3C marketing equation
16.3.7.4 Company Strategy & Channel Management
17. Research Sources & Primary Verbatim

Inquire further details about this report at: [email protected]

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com